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Purpose: To map and identify the genetic mutation underlying X-linked congenital nystagmus in a Chinese family.
Methods: Genomic DNA was prepared from peripheral blood, and linkage analysis was performed using short tandem
repeat (STR) polymorphism markers. We used Cyrillic software to manage pedigree and haplotype data and used MLINK
to calculate LOD scores. Dye-terminator cycle-sequencing was used to detect the sequence variation of polymerase chain
reaction (PCR)-amplified exons.
Results: Linkage analysis mapped the disease-causing gene to Xp22.3 with a significant two-point LOD score (Z) at
marker DXS7103 (Z=3.16, recombination fraction [θ]=0). Haplotype analysis in this region supported the result. In
analyzing the candidate gene in the linked region, we found a 37-bp deletion in exon 1 of GPR143 in all male patients.
Conclusions: The revealed 37-bp deletion in GPR143 is frameshift and is predicted to result in a truncated protein of 93
residues. These results indicate that this novel GPR143 mutation is associated with the congenital nystagmus observed in
this Chinese family.
Nystagmus  is  an  ocular  disorder  characterized  by
repetitive and involuntary oscillation of the eyeball [1]. Visual
function can be significantly reduced owing to constant eye
movement, but the degree of visual impairment varies [2].
This disease can be secondary to other visual or neurological
disease  or  can  occur  as  an  isolated  inherited  trait  termed
congenital nystagmus (CN). The condition is present at birth
or  develops  within  the  first  few  months  of  life  with  an
estimated annual incidence of 1/20,000 [3]. CN is genetically
heterogeneous, and several patterns of inheritance of CN have
been  described  including  autosomal  dominant  [4-6],
autosomal recessive [7], X-linked dominant [7], and X-linked
recessive patterns [8,9]. It has been suggested that X-linked
patterns of genetic inheritance with incomplete penetrance are
probably most common. Three different genetic loci for X-
linked CN have been mapped to chromosomes Xp22 [10],
Xp11.3–11.4 [8], and Xq26-X27 [7,9].
To  date,  two  genes,  the  FERM  domain-containing  7
(FRMD7)  gene  and  the  G  protein-coupled  receptor  143
(GPR143) gene, have been identified as disease-causing genes
for CN. FRMD7 is at the known locus, Xq26–27, and multiple
mutations of FRMD7 have been reported since it was first
identified  in  2006  [11-14].  Another  gene,  GPR143,  also
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known as the OA1 gene at Xp22, causes ocular albinism upon
mutation  [15,16].  Ocular  albinism  is  an  X-linked  type  of
albinism that mainly effects pigment production in the eye,
resulting in hypopigmentation of the retina, foveal hypoplasia,
reduction of visual acuity, nystagmus, and optic misrouting
[15,16]. However, a recent study of a Chinese family with X-
linked CN, occurring without the classical phenotype (retinal
hypopigmentation)  of  ocular  albinism  but  only  with
nystagmus (some patients also suffer from foveal hypoplasia
and reduction of visual acuity), has identified a GPR143 gene
mutation [10]. It is suggested that the GPR143 mutation may
also produce CN as the most prominent manifestation.
In this study, we collected data from a four-generation
Chinese family with X-linked congenital nystagmus. All the
affected individuals suffer from nystagmus and amblyopia but
without any sign of retinal hypopigmentation. We mapped the
disease-causing gene to Xp22.3 and found a 37-bp deletion in
exon 1 of GPR143 in all affected male and female carriers.
Our results indicate that this novel GPR143 mutation might
cause the X-linked CN in this family.
METHODS
Family data and extraction of human genomic DNA: The
study  had  the  approval  of  the  local  and  regional  ethics
committee and conformed to the tenets of the Declaration of
Helsinki.  A  four-generation  Han  Chinese  family  with  X-
linked CN was identified in Zhengzhou, Henan Province,
China. It consisted of 33 living members and involved nine
affected males (Figure 1). All members of this family were
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1015diagnosed  carefully  by  ocular  examinations,  which  were
performed  with  slit  lamp  biomicroscopy  and  direct  and
indirect  ophthalmoscopy.  One  hundred  unrelated  Han
Chinese individuals were recruited as the control subjects and
were clinically examined by the Ruijing Hospital, Shanghai
Jiao Tong University School of Medicine, Shanghai, China.
All the individuals in the control group were healthy and
without any history of familial inherited disease. Peripheral
blood was obtained from 30 family members (except III:12,
III:13, and III:14) and the control subjects after obtaining
informed consent. The genomic DNA was prepared using the
QIAmp  DNA  Blood  Kit  (Qiagen,  Hilden,  Germany)
according to the manufacturer’s instructions.
Genotyping and linkage analysis: Genotyping was performed
using  26  fluorescent  microsatellite  markers  covering  the
entire X chromosome. All of the short tandem repeat (STR)
markers selected from the combined Genethon, Marshfield,
and  deCODE  genetic  linkage  maps  (National  Center  for
Biotechnology  Information,  Bethesda,  MD,  NCBI)  were
amplified  with  M13-tailed  primers  in  the  presence  of  an
IRDye800 labeled M13-universal primer (Li-Cor, Lincoln,
NE) and detected with a Li-Cor 4200L DNA sequencer (Li-
Cor). A two-point linkage analysis was conducted using a
LINKAGE (version 5.1) software package [17]. This disease
was specified as an X-linked recessive trait with penetrance
of 1.0 in males, and the affected allele frequency was assumed
to be 0.001. Pedigree drawing and haplotype construction
were  done  using  Cyrillic  (version  2.0)  software  (Cyrillic
software, Oxfordshire, UK).
Mutation  detection:  DNA  fragments  encompassing  the
coding and adjacent intron regions of the G protein-coupled
receptor 143 (GPR143, OMIM 300500) gene were amplified
by polymerase chain reaction (PCR) using nine pairs of gene-
specific primers. Each fragment was sequenced using the ABI
BigDye  Terminator  Cycle  Sequencing  kit  (Applied
Biosystems, Foster City, CA) and an ABI 3100 sequencer
according to the manufacturer’s protocol.
RESULTS
Pedigree of the X-linked congenital nystagmus family: In this
family, all affected individuals were male and all obligate
carriers had no sign of nystagmus (Figure 1). The disease was
transmitted from female carrier to affected son and was an
apparent X-linked recessive trait. We then determined the
disease to exhibit an X-linked recessive inheritance pattern
using linkage analysis. DNA was available from 30 family
members  in  three  generations  (including  nine  affected
individuals),  and  genotyping  was  conducted  on  the  X
chromosome.
Figure 1. The pedigree and haplotype analysis of the Chinese congenital nystagmus subject family. The proband is marked with an arrow.
Eight markers are listed from top to bottom: telomere - DXS6807 - DXS7103 - DXS9902 - DXS9896 - GATA186D06 - DXS8015 - DXS6810
- DXS8035 - centromere. Blackened regions of haplotypes indicate linkage between the markers and the disease. Question marks indicate
that the genotype is not determined.
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1016Linkage analysis: Upon analysis of the X chromosome scan,
the highest two-point LOD score (Z) was found for marker
DXS7103 (Z=3.16, θ=0). One STR marker, DXS6807, which
was near DXS7103, also gave a positive LOD score of 1.28 at
θ=0 (Table 1). Other markers showed LOD scores of -∞ or
<1. Therefore, we mapped the critical region for CN to a 22
cM  interval  between  the  telomeric  boundary  and  marker
DXS9902. Haplotypes in this region supported the linkage
results (Figure 1). Both the affected individuals, III: 7 and III:
23, had recombinations between DXS7103 and DXS9902
while the non-affected male, IV: 2, also had a recombination
in this region.
Mutation of the GPR143 gene: GPR143 was within the critical
interval and was thought to be a strong candidate for mutation.
Upon complete analysis of the coding and the adjacent intron
regions of GPR143, a deletion in exon 1 was identified in all
affected males (Figure 2). All obligate female carriers were
heterozygous for the deletion. This deletion was not detected
in normal members of the family and in other normal control
subjects. It is 37 bp long and occurs at position 222 of the
cDNA. This frameshift deletion introduces a subsequence
premature  termination  codon  downstream.  The  human
GPR143 gene encodes a protein of 404 amino acids while this
deletion is predicted to result in a truncated protein with 93
amino acids. This change is predicted to result in loss of
function.  Our  findings  suggest  that  this  GPR143  deletion
plays a causative role in the pathogenesis of X-linked CN in
this family.
DISCUSSION
In  this  study,  we  have  mapped  the  CN  disease  gene  on
chromosome Xp22 and identified a novel deletion in exon 1 of
GPR143. All male patients and obligate carriers have this
mutation while the other normal members of the family and
the controls have not. We also screened another gene known
to  be  involved  in  the  development  of  CN,  FRMD7,  and
identified no mutation. Thus, the FRMD7 mutations should
not be causative in CN development in this family. These
results provide strong evidence for GPR143 mutation in the
pathogenesis of X-linked CN.
The coding sequence of GPR143 is divided into nine
exons and encodes a protein of 404 amino acids containing
seven  putative  transmembrane  domains  and  one  potential
glycosylation site using an asparagine at codon 106 [18].
GPR143 is expressed mainly in pigment cells of the skin and
eyes.  It  is  located  on  the  membrane  of  an  intracellular
organelle, the melanosome, found in pigment cells and plays
an  important  role  in  melanosomal  biogenesis  [19,20].
GPR143  mutations  can  cause  ocular  albinism,  a  disease
characterized  by  severe  retinal  hypopigmentation,  foveal
hypoplasia, reduction of visual acuity, and optic misrouting
[19]. This disorder is transmitted as an X-linked trait with
affected  males  showing  the  complete  phenotype  and
heterozygous females showing only minor or no retinal and
cutaneous signs of the disease [19]. Thus, this disorder is
described  as  showing  an  X-linked  recessive  pattern  of
inheritance  in  some  reports  [21].  Previous  studies  have
included an extensive survey of GPR143 mutations in a large
collection of patients with ocular albinism [15,18,21,22]. The
GPR143 mutations that cause ocular albinism vary. Some are
loss of function mutations, which are deletion, frameshift, and
nonsense mutations [15,21,22]. Some are missense mutations
that may cause defective intracellular transport or processing
of the GPR143 protein [18]. However, the GPR143 mutation
in the Chinese population is rarely reported. The mutation
described here is only the second GPR143 mutation reported
in the Chinese population.
Nystagmus has been reported in ocular albinism patients
with mutations in GPR143 and is thought to be a secondary
phenotype in these patients [23]. However, in our family of
subjects, none of the patients with the GPR143 mutation had
the classical phenotype of ocular albinism. Mutation analysis
TABLE 1. TWO-POINT LOD SCORE RESULT BETWEEN THE DISEASE GENE AND EIGHT MARKERS OF CHROMOSOME X.
Marker CM
Two-point LOD score at θ=
0 0.01 0.05 0.1 0.2 0.3 0.4
DXS6807 4.39 1.28 1.26 1.17 1.06 0.82 0.57 0.30
DXS7103 10.93 3.16 3.11 2.92 2.65 2.08 1.41 0.65
DXS9902 22.04 -∞ 1.50 -0.23 0.21 0.44 0.37 0.15
DXS9896 39.52 -∞ -6.79 -3.43 -2.10 -0.97 -0.48 -0.23
GATA186D06 44.96 -∞ -2.95 -1.58 -1.01 -0.49 -0.23 -0.08
DXS8015 53.71 -∞ -6.57 -3.21 -1.87 -0.72 -0.23 -0.04
DXS6810 63.59 -∞ -1.64 -0.95 -0.65 -0.37 -0.20 -0.09
DXS8035 65.79 -∞ -6.89 -3.50 -2.13 -0.92 -0.36 -0.08
Z values for eight markers on chromosome Xp are shown, and the maximum Z value occurs at marker DXS7103.
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in exon 1. This mutation leads to frameshift and introduces a
subsequent premature termination codon downstream (Figure
2C). The predicted protein has only 93 amino acids and is
much shorter than the normal full-length protein of 404 amino
acids,  suggesting  that  this  is  a  loss  of  function  mutation.
Because the deletion mutation is predicted to introduce a
premature stop codon, the mutant transcript is likely to be
degraded by the nonsense-mediated mRNA decay (NMD)
pathway [24]. If prevented by NMD, the truncated protein
may not be produced. It should be noted that this hypothesis
has not been tested directly as we were unable to obtain related
RNA of disease tissues.
This result is consistent with that of the first GPR143
mutation  finding  in  a  Chinese  family  with  CN  [10].  The
patients  in  that  family  also  had  CN  without  the  classical
phenotype of ocular albinism and had a missense mutation,
which resulted in the substitution of a Ser residue with a Phe
residue in exon 2. This mutation occurred at a residue, which
is evolutionarily highly conserved from Xenopus and fish to
humans and was likely to cause the functional change, but the
extent of its influence was unknown. As compared to that
finding,  the  deletion  found  in  our  study,  which  causes
frameshift and apparent loss of function, provides stronger
evidence of an association between the GPR143 mutation and
CN disease in the Chinese population. In addition, the Chinese
population might have a variant phenotype of mutation in
GPR143 with congenital nystagmus as the most prominent
and only consistent finding. Different responses to GPR143
mutations have been previously reported among other non-
Chinese affected males (African-American and Caucasian)
with different degrees of retinal hypopigmentation and other
phenotypes [21]. This indicates that other factors such as
genetic background and/or environmental factors may modify
the phenotypes caused by GPR143 mutations.
Our findings provide one genetic basis for CN in the
Chinese  population,  and  the  GPR143  gene  should  be
considered in mutation testing programs for this disorder.
However, the specific molecular mechanism by which these
GPR143 mutations result in CN is still unknown, and future
functional studies may provide new insights.
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